Discover
ENSC
Ensysce Biosciences, Inc.
0.53
60 x 0.20
2 x 0.51
bid
ask
+
0.07
15.07%
31 @ 07:59 PM
0.50 -0.02 (4.33%)
| Ytd | -42.72% | |
| 1y | -77.38% |
0.48
day range
0.55
0.25
52 week range
2.57
| Open | 0.48 | Prev Close | 0.46 | Low | 0.48 | High | 0.55 | Mkt Cap | 10.25M |
| Vol | 2.68M | Avg Vol | 14.21M | EPS | -2.47 | P/E | N/A | Forward P/E | -9.08 |
| Beta | 0.64 | Short Ratio | 0.12 | Inst. Own | 22.26% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-14 | 50-d Avg | 0.41 | 200-d Avg | 0.47 | 1yr Est | 102.00 |
| Income Statement | |||
| Operating Expenses | 2.58M | ||
| Research and Development Expense | 2.47M | ||
| Selling, General and Administrative Expense | 1.27M | ||
| Operating Income | -2.58M | ||
| Interest Expense | 320.00 | ||
| Net Income | -2.57M | ||
| Net Income Common Stock | -2.57M | ||
| Net Income Common Stock (USD) | -2.57M | ||
| Consolidated Income | -2.57M | ||
| Net Income to Non-Controlling Interests | -166.00 | ||
| Earnings per Basic Share | -0.20 | ||
| Earnings per Basic Share (USD) | -0.20 | ||
| Earnings per Diluted Share | -0.20 | ||
| Earning Before Interest & Taxes (EBIT) | -2.57M | ||
| Earning Before Interest & Taxes (USD) | -2.57M | ||
| Weighted Average Shares | 13.04M | ||
| Weighted Average Shares Diluted | 13.04M | ||
| Balance Sheet | |||
| Cash and Equivalents | 676.70K | ||
| Cash and Equivalents (USD) | 676.70K | ||
| Trade and Non-Trade Receivables | 416.81K | ||
| Current Assets | 2.85M | ||
| Property, Plant & Equipment Net | 111.06K | ||
| Total Assets | 2.96M | ||
| Debt Current | 196.84K | ||
| Total Debt | 196.84K | ||
| Current Liabilities | 4.07M | ||
| Total Liabilities | 4.07M | ||
| Accumulated Retained Earnings (Deficit) | -145.85M | ||
| Shareholders Equity | -781.70K | ||
| Shareholders Equity (USD) | -781.70K | ||
| Assets Non-Current | 111.06K | ||
| Total Debt (USD) | 196.84K | ||
| Trade and Non-Trade Payables | 1.98M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 6.53K | ||
| Net Cash Flow from Financing | 1.89M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -68.78K | ||
| Net Cash Flow from Operations | -1.96M | ||
| Share Based Compensation | 1.87K | ||